The Safety and Effectiveness of Nevirapine Plus Nelfinavir in HIV-1 Infected Patients Who Have Taken Stavudine - Contacts and Locations

Home

The Safety and Effectiveness of Nevirapine Plus Nelfinavir in HIV-1 Infected Patients Who Have Taken Stavudine

This study has been completed.

Study NCT00002381. Last updated on June 23, 2005. Information provided by NIH AIDS Clinical Trials Information Service

Please refer to this study by its ClinicalTrials.gov identifier: NCT00002381

Locations


United States, California
	Saint Francis Mem Hosp / HIV Care Unit
	San Francisco, California, United States, 94109

United States, Rhode Island
	Roger Williams Med Ctr
	Providence, Rhode Island, United States, 02908

Sponsors and Collaborators

Boehringer Ingelheim Pharmaceuticals